摘要
目的：探讨克林霉素磷酸酯治疗呼吸系统感染的临床研究。方法选取2013年11月～2014年11月我院接诊的40例呼吸系统感染患者，随机分为实验组和对照组，实验组采用克林霉素磷酸酯药物，对照组采用盐酸左氧氟沙星药物，观察两组患者的治疗效果。结果实验组患者的治疗总有效率、致病菌的清除率及不良反应的发生率优于对照组，差异有统计学意义（P〈0.05）。结论克林霉素磷酸酯治疗呼吸系统感染的效果显著，可以提高患者的治愈率，降低不良反应的发生率。
Objective Clindamycin phosphate in treatment of respiratory infection is to be studied. Methods Chose 40 patients of respiratory infection that were treated in hospital from November 2013 to November 2014 and separated them into study group and control group at random,patients in study group were given clindamycin phosphate treatment; while patients in control group were given levofloxacin hydrochloride treatment; and then observed and compared treatment efficacy between two groups. Results Treatment efficacy,pathogen clearance rate and side-effect incidence in study group were much more favorable than counterparts in control group,there was a treatment differential between two groups and such a differential had statistic value （P〈0.05）. Conclusion Clindamycin phosphate is of efficiency in treatment of respiratory infection; it is conducive to increasing patients’cure rate and reducing side-effect incidence,which is quite worthwhile to be promoted and applied clinical y.
出处
《中国卫生标准管理》
2015年第7期171-172,共2页
China Health Standard Management
